Top Markets
Coin of the day
TFBS Bioscience Inc. TFBS Bioscience Inc.

TFBS Bioscience Inc.

6939
Rank in Stocks #29499
TFBS Bioscience Inc. functions as a contract research organization (CRO),... TFBS Bioscience Inc. functions as a contract research organization (CRO), specializing in offering biological analysis and testing services throughout Taiwan. The company plays a crucial role in supporting advanced medical innovations by fabricating viral vectors, which are essential for cell and gene therapy products. Furthermore, TFBS Bioscience conducts comprehensive biosafety and final product release evaluations for a diverse range of biopharmaceutical items, including cell and gene therapies, vaccines, and other biologics. Established in 2016, the firm's main operational base is located in New Taipei City, Taiwan.
Share Price
$0.59623177
Market Cap
$20.88M
Change (1 day)
-0.79%
Change (1 year)
-26.69%
Country
TW
Trade TFBS Bioscience Inc. (6939)

Category

Operating Margin for TFBS Bioscience Inc. (6939)
Operating Margin as of 2026 TTM: 0.00%
According to TFBS Bioscience Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for TFBS Bioscience Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.69% -
US
20.42% -
US
0.00% -
CN
-10.70% -
US
32.03% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.